ADVERTISEMENT
Isolated Realistic Coronavirus Covid-19 Molecule in a Biological Environment stock photo
Tweak to N Protein Makes Delta Variant More Infectious
Using a novel lab technique, researchers identified a mutation that allows the virus to insert more genetic material into host cells.
Tweak to N Protein Makes Delta Variant More Infectious
Tweak to N Protein Makes Delta Variant More Infectious

Using a novel lab technique, researchers identified a mutation that allows the virus to insert more genetic material into host cells.

Using a novel lab technique, researchers identified a mutation that allows the virus to insert more genetic material into host cells.

infectious disease, immunology

white adult mouse with 4 pups on white background
Mice that Survive Infection Pass on Stronger Immunity
David Adam | Oct 18, 2021 | 3 min read
Offspring of animals subjected to a real or simulated pathogen were more able to fend off disease, a study finds.
moderna and pfizer vaccine vials
Moderna vs. Pfizer: Is There a “Best” mRNA Vaccine?
Alejandra Manjarrez, PhD | Sep 24, 2021 | 10 min read
Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Moderna’s elicits a stronger immune response and might be better at preventing breakthrough infections.  
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
The Scientist and 10x Genomics | 1 min read
Researchers identify signatures that predict how a person will respond to an immune system stimulus.
An image depicting where covid affects the body
SARS-CoV-2’s Wide-Ranging Effects on the Body
Diana Kwon | Sep 1, 2021 | 8 min read
Researchers’ painstaking examinations have begun to reveal how the virus wreaks havoc in multiple organs and tissues.
close-up of empty vaccine vials in a factory
The Quest for a Universal Coronavirus Vaccine
Diana Kwon | Jun 29, 2021 | 8 min read
Scientists are on the hunt for a shot that will protect against not only SARS-CoV-2, but other members of its family that may emerge in the future.
Understanding Immune-Mediated Damage After Respiratory Infection
The Scientist Creative Services Team in collaboration with 10x Genomics | 1 min read
Paul Thomas from St. Jude Children’s Research Hospital will discuss how he used single cell and spatial transcriptomics to discover the underlying mechanism of an inflammatory immune response in the lungs.
An illustration of several human heads wearing masks
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Jef Akst | Jun 18, 2021 | 4 min read
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
mis-c multisystem inflammatory syndrome in children covid-19 coronavirus pandemic sars-cov-2 antibody cardiac inflammation icu intensive care kids infection vomiting abdominal pain diarrhea fever
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Kerry Grens | Apr 7, 2021 | 2 min read
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
The Brain on COVID-19
The Scientist | 1 min read
Connecting the dots between COVID-19 and neurological disorders
AstraZeneca, University of Oxford, vaccine, COVID-19, SARS-CoV-2, pandemic, coronavirus, vaccination, safety, Europe
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021 | 2 min read
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
Interim Report on Origin of SARS-CoV-2 Scrapped by WHO
Lisa Winter | Mar 5, 2021 | 2 min read
Instead, the full report will be available in mid-March.
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
The Scientist | 1 min read
Alessandro Sette and Shane Crotty discuss the T cell response to SARS-CoV-2 and the implications for vaccine design and robust immune memory.
Sex Differences in Immune Responses to Viral Infection
Catherine Offord | Mar 1, 2021 | 10+ min read
Stronger interferon production, greater T cell activation, and increased susceptibility to autoimmunity are just some of the ways that females seem to differ from males.
Infographic: How SARS-CoV-2 Immune Responses May Differ by Sex
Catherine Offord | Mar 1, 2021 | 2 min read
Males and females show differences in gene expression, cell activation, and antibody production in response to some viral infections, but whether these influence COVID-19 outcomes is still unclear.
Investigating the Immune Response Using Advanced Flow Cytometry
The Scientist | 1 min read
Discover how researchers are using flow cytometry to delve into the inner workings of the immune life cycle!
cancer blood hematologic leukemia solid tumor covid-19 sars-cov-2 coronavirus pandemic mortality t cell b cd8+ cd4+ immunology chemotherapy
COVID-19 More Deadly with Blood than Solid Cancer: Study
Marcus A. Banks | Feb 16, 2021 | 4 min read
Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.
escape mutant vaccine resistance covid-19 sars-cov-2 sars2 coronavirus pandemic evolution variants antibodies neutralizing
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Chris Baraniuk | Feb 4, 2021 | 6 min read
With many millions of people waiting several weeks to receive a second COVID-19 vaccine dose in some countries, experts consider the possibility that SARS-CoV-2 could evolve vaccine resistance.
Longitudinal Immune Profiling Reveals Key Immune Signatures Associated with COVID-19
The Scientist | 1 min read
Madhvi Menon will discuss immune profiling of COVID-19 patients and Jyoti Phatak-Sheldon will highlight the use of RNAscope in situ hybridization in SARS-CoV-2 research.
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Ashley Yeager | Nov 23, 2020 | 4 min read
Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.
ADVERTISEMENT